GREM1 and breast cancer: This same group identified novel downstream signaling modalities for GREM1/EGFR activation, including STAT3/ERK/AKT activation and increased matrix metalloproteinase (MMP13) activity in breast cancer cells, leading to increased breast cancer cell invasion (Kim et al. 2020; Sung et al. 2020a, b).